home All News open_in_new Full Article

Akeso wins Chinese approval for cancer drug positioned to rival Merck’s Keytruda

Akeso wins Chinese approval for cancer drug positioned to rival Merck’s Keytruda  statnews.com


today 10 h. ago attach_file Events

attach_file Sport
attach_file Economics
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 2165450842
Add Watch Country

arrow_drop_down